Irene García‐Cadenas

Author

Hospital de Sant Pau

Also Known As

I. García‐Cadenas, Irene Garcia-Cadenas, Irene Garcia-cadenas, Irene García-Cadenas, Irene García‐Cadenas, Juan Bergua

Publications

503

Citations

H-Index

Concepts

All Affiliations

Hospital de Sant Pau Universitat Autònoma de Barcelona Josep Carreras Leukaemia Research Institute Hospital Clínico Universitario de Valencia Vall d'Hebron Hospital Universitari

About

Irene García‐Cadenas is an author at Hospital de Sant Pau specializing in medicine, immunology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	204
2	Blood Transplantation	1	1	21
3	Cell Biology	1	1	183
4	Immunology	1	1	183
5	Marrow Transplantation	1	1	21

Irene García‐Cadenas

Publications

478

Citations

H-Index

Page 1

	Year	Citations
CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib Hardikkumar Jetani, Irene García‐Cadenas, Thomas Nerreter, Leukemia Car T-cellsSignal TransductionImmunologyFlt3-inhibitor CrenolanibMedicine	2018	183
Risk factors and outcome of COVID-19 in patients with hematological malignancies José Luís Piñana, Rodrigo Martino, Irene García‐García, Experimental Hematology and Oncology	2020	152
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders José Luís Piñana, Lucía López‐Corral, Rodrigo Martino, Journal of Hematology & Oncology	2022	38
A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis José Luís Piñana, Alejandro Pérez‐Pitarch, Irene García‐Cadenas, Biology of Blood and Marrow Transplantation	2017	24
Usefulness of thrombopoietin receptor agonists for persistent clinically relevant thrombocytopenia after allogeneic stem cell transplantation Anna Bosch, Irene García‐Cadenas, Elisa Roldán, European Journal Of Haematology	2018	22
Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and Challenges Sara Redondo, Albert Esquirol, Silvana Novelli, Transplantation and Cellular Therapy Transplantation SurgeryGradual TaperingTransplantationGvhd FlareReal-world Data	2021	21
Do Patients and Physicians Agree When They Assess Quality of Life? Anna Barata, Rodrigo Martino, Ignasi Gich, Biology of Blood and Marrow Transplantation	2017	17
Phase 1 Clinical Trial of Memory-Enriched Academic HSP-CAR30 for the Treatment of Relapsed/Refractory Hodgkin Lymphoma and CD30+ T-Cell Lymphoma: Clinical and Biological Studies Ana Carolina Carolina Caballero Gonzalez, Laura Escribà-García, Rosanna Montserrat, Blood	2022	11
Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients Marta Santaliestra, Ana Garrido, Maite Carricondo, European Journal Of Haematology	2019	10

Page 1